NCBiotech News

Four of North Carolina's key agricultural partners are coming together in a collaborative effort to highlight the contributions women have made to the agriculture industry in North Carolina.

Leading women across the state are changing the future beyond the farm. Innovations, resources, opportunities and experiences will be shared on tour and social platforms to showcase the impact women have on North Carolina’s agriculture industry.

Durham-based Chimerix,has committed $30 million and10 million shares of its common stock to buy exclusive worldwide rights to a leukemia drug under development by Cantex Pharmaceuticals Inc.

RTP's AskBio has entered a strategic partnership with Boston's Selecta to boost gene therapy's potential for re-dosing if needed.

After more than a half century in New Jersey, the Inter-regional Research Project No. 4, a national agricultural research organization, is moving from the Garden State to Raleigh.

RTP plant genomics startup Pairwise and NCSU are collaborating in a unique public-private partnership to vastly accelerate the search for better berries.

North Carolina's Research Triangle area led the nation last year in per-capita funding from the National Institutes of Health.

North Carolina is the top-ranked state for Economic Growth Potential, second in Installed Solar Capacity and third in Biotechnology Strength in Business Facilities’ 15th Annual Rankings Report for 2019.

Merck announced today that it will invest at least $680 million and add some 425 new jobs over the next few years, including an expansion of its Durham vaccine manufacturing facility and a $30 million packaging line addition at its Wilson plant.

Registration is now open for the 21st annual Southeast BIO Investor & Partnering Forum to be held in Miami on November 6 and 7.

North Carolina life science entrepreneurs gained lucrative insight from a panel of seasoned peers and investors at the most recent “Becoming an Investor-Ready Entrepreneur” event from the Small Business and Technology Development Center.

Grifols’ product portfolio just got a little larger with U.S. Food and Drug Administration approval of Xembify, a treatment for immune deficiency.

North Carolina is ready to lead in military medical technology, said Scott Dorney, head of the NC Military Business Center, to attendees at the 2019 Warfighter symposium in Chapel Hill.

Milestone Pharmaceuticals, a Montreal company with a growing Charlotte subsidiary, has something in development that investors like: a nasal spray called Etripamil, in Phase 3 clinical trials to treat a form of heart arrhythmia.

Climate held sway at this year's annual Ag Tech Professional Forum Summer Social, where like-minded people networked and learned.

In speculating about the future of agriculture, David Hollinrake, president of Syngenta Seeds and North America region director, is certain of one thing: “It’s not going to be my daddy’s farm moving forward.”